These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27918378)

  • 1. Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.
    Lee AM; Burns JC; Tremoulet AH
    Pediatr Infect Dis J; 2017 Apr; 36(4):435-437. PubMed ID: 27918378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease.
    Morikawa Y; Sakakibara H; Kimiya T; Obonai T; Miura M;
    Vaccine; 2021 Sep; 39(39):5680-5687. PubMed ID: 34452773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live vaccines following intravenous immunoglobulin for Kawasaki disease: Are we vaccinating appropriately?
    Cardenas-Brown C; Lucas RD; Buttery J; Britton PN; Wood N; Singh-Grewal D; Burgner D
    J Paediatr Child Health; 2023 Nov; 59(11):1217-1222. PubMed ID: 37664891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Priorix Tetra: a new combined vaccine against measles, rubella, mumps and varicella].
    Gabutti G; Azzari C
    Minerva Pediatr; 2008 Aug; 60(4):429-41. PubMed ID: 18511895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease: A Postmarketing Surveillance in Japan (SAKURA Study).
    Miura M; Kobayashi T; Igarashi T; Hamada H; Iwata N; Sasaki Y; Matsukawa M; Sato N; Kubo H; Takei S
    Pediatr Infect Dis J; 2020 Jan; 39(1):41-47. PubMed ID: 31815838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab as the First Retreatment in Patients with Kawasaki Disease Resistant to Initial Intravenous Immunoglobulin.
    Youn Y; Kim J; Hong YM; Sohn S
    Pediatr Infect Dis J; 2016 Apr; 35(4):457-9. PubMed ID: 26673981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations.
    Ohnishi Y; Okada S; Kawakami-Miyake A; Furuta T; Fukano R; Yasudo H; Shimokawa M; Hasegawa S
    Pediatr Infect Dis J; 2022 Sep; 41(9):e388-e392. PubMed ID: 35895884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH; Hirai HW; Tsoi KK
    Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease.
    Tacke CE; Smits GP; van der Klis FR; Kuipers IM; Zaaijer HL; Kuijpers TW
    J Allergy Clin Immunol; 2013 Jun; 131(6):1701-3. PubMed ID: 23498596
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
    Blatter MM; Klein NP; Shepard JS; Leonardi M; Shapiro S; Schear M; Mufson MA; Martin JM; Varman M; Grogg S; London A; Cambron P; Douha M; Nicholson O; da Costa C; Innis BL
    Pediatr Infect Dis J; 2012 Aug; 31(8):e133-40. PubMed ID: 22622699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Sanftenberg L; Schrörs HJ; Schelling J
    Vaccine; 2016 Jul; 34(34):3938-41. PubMed ID: 27318420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella.
    Streng A; Liese JG
    Vaccine; 2014 Feb; 32(8):897-900. PubMed ID: 24412300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
    Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.